Article Versions Notes

Silla A, Fogacci F, Punzo A, Hrelia S, Simoni P, Caliceti C, Cicero AFG. Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk. Antioxidants. 2023; 12(3):578. https://doi.org/10.3390/antiox12030578

Silla, Alessia, Federica Fogacci, Angela Punzo, Silvana Hrelia, Patrizia Simoni, Cristiana Caliceti, and Arrigo F. G. Cicero. 2023. "Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk" Antioxidants 12, no. 3: 578. https://doi.org/10.3390/antiox12030578

Silla, A., Fogacci, F., Punzo, A., Hrelia, S., Simoni, P., Caliceti, C., & Cicero, A. F. G. (2023). Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk. Antioxidants, 12(3), 578. https://doi.org/10.3390/antiox12030578